Toxicities reduced treatment

OTHER3 trials

Sponsors

Fudan University, Chaosu Hu

Conditions

De-escalationNasopharyngeal CarcinomaOropharyngeal CancerOropharyngeal Carcinoma

Phase 2

PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC

Fudan UniversityOropharyngeal Cancer

Start: 2022-06-29End: 2025-07-30Target: 60Updated: 2023-12-05

Unknown Phase

De-escalation Protocols in HPV-related Oropharyngeal Carcinoma in Chinese Populations

Fudan UniversityDe-escalation, Oropharyngeal Carcinoma

Start: 2019-07-01End: 2020-12-31Target: 83Updated: 2019-07-09

De-escalation Protocols in Locoregionally Advanced Nasopharyngeal Carcinoma

Chaosu HuNasopharyngeal Carcinoma

Start: 2019-11-01End: 2022-12-31Target: 118Updated: 2019-11-08

Related Papers

MR radiomics unveils neoadjuvant chemo-responsiveness with insights into selective treatment de-intensification in HPV-positive oropharyngeal carcinoma.

2024-09-27

Selective treatment de-intensification with reduced-dose radiation and omitted concurrent chemotherapy guided by response to induction chemotherapy in HPV-associated oropharyngeal squamous cell carcinoma: A single-arm, phase II trial (IChoice-01).

Journal of Clinical Oncology2022-06-01